Idera Pharmaceuticals is a clinical stage biotechnology company developing a novel approach to the treatment of autoimmune diseases and certain genetically defined forms of B-cell lymphoma. Learn More
3.6.14Idera to Host Conference Call and Webcast to Report Fourth Quarter and Full Year 2013 Financial Results on Thursday, March 13, 2014
2.26.14Idera to Present at the 34th Annual Cowen & Company Health Care Conference
Idera is advancing to the clinic in genetically defined forms of B-cell lymphoma: activated B-cell-like diffuse large B-cell lymphoma (ABC-DLBCL) and Waldenström’s macroglobulinemia.
Back to top
“TLR structure” by The cat, used under GNU Free Documentation License / Cropped and colored background from original.
© 2014 Idera Pharmaceuticals